NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CG labs segment comprises the CG Converting and Packaging, LLC used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its hydrogel consumer products are marketed under the brand names MedaGel and LumaGel Beauty. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. It also specializes in eye and eyelash consumer products.
企業コードNXGL
会社名Nexgel Inc
上場日Dec 22, 2021
最高経営責任者「CEO」Mr. Adam Levy
従業員数19
証券種類Ordinary Share
決算期末Dec 22
本社所在地2150 Cabot Blvd West,
都市LANGHORNE
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号19047
電話番号12157028550
ウェブサイトhttps://nexgel.com/
企業コードNXGL
上場日Dec 22, 2021
最高経営責任者「CEO」Mr. Adam Levy
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし